CDC in Georgia

Epidemiologic investigation of the novel orthopox (Akhmeta Virus) in 2013.

Epidemiologic investigation of the novel orthopox (Akhmeta Virus) in 2013.

The Centers for Disease Control and Prevention (CDC) first engaged with the country of Georgia in 1995 to assist in investigation of a diphtheria outbreak. In partnership with Georgia’s National Center for Disease Control (NCDC) and government ministries, CDC strengthens capacity to detect and respond to disease outbreaks. CDC plays a key role in Georgia’s COVID-19 response, hepatitis C virus elimination, and measles, rabies, and polio eradication.

CDC Impact in Georgia

Global Health Security

Georgia’s focus on health security began when the country volunteered to pilot an early version of the Global Health Security Agenda (GHSA) Joint External Evaluation (JEE) tool. In 2021, CDC joined Georgia as co-lead of the GHSA Real-Time Surveillance Action Package. CDC and NCDC support GHSA research and projects including:

  • Strengthening the national laboratory system
  • Enhancing real-time disease surveillance
  • Supporting genomic research of the hepatitis C virus
  • Assisting in outbreak investigations of zoonotic, foodborne, and respiratory diseases
  • Strengthening molecular detection of drug resistance mechanisms
  • Strengthening capacity of the Emergency Operations Center


The first case of COVID-19 in Georgia was reported on February 26, 2020. Existing collaborations between CDC and Georgia partners were critical to leveraging the molecular diagnostic infrastructure for hepatitis C, expert workforce, and quality assurance programs for SARS-CoV-2 testing. In March 2021, CDC supported the establishment of SARS-CoV-2 sequencing capacity to enhance national and global surveillance of SARS-CoV-2 variants. CDC collaborates on key COVID-19 preparedness and response activities including:

  • Establishment of Georgia’s Emergency Operations Center
  • Integration of COVID-19 into existing disease surveillance platforms
  • Population-based SARS-CoV-2 seroprevalence surveys

In 2021, CDC supported establishment of External Quality Assurance (EQA) programs for COVID-19 diagnostic testing in 60 laboratories across Georgia

Icon Covid

As of December 2021, Georgia sequenced >900,000 COVID-19 cases and shared >700 SARS-CoV-2 sequences with the Global Initiative on Sharing All Influenza Data (GISAID)

Icon training

CDC worked with partners to train nearly 500 public health professionals in infection prevention and control (IPC) protocols, laboratory diagnostics, rapid response, emergency operations, disease surveillance, contact tracing, and WASH

Icon world handshake

CDC proposed IPC protocols that the Ministry of Health, Labor, and Social Affairs implemented for triage at health facilities, disease surveillance of healthcare workers, use of personal protective equipment, and facility-readiness assessment

One Health

CDC works with partners in Georgia to approach disease from a One Health perspective, recognizing that the health of people is connected to the health of animals and the environment. CDC collaborates with Georgia’s National Food Agency (NFA) and NCDC to increase laboratory disease surveillance and outbreak investigation, response, and control of zoonotic, food-borne, water-borne, and enteric diseases. CDC implements the One Health approach by working with partners to:

  • Develop disease control guidelines
  • Conduct educational training sessions for zoonotic disease prioritization and identification of pathogens
  • Pilot the transition to whole-genome sequencing for enteric disease surveillance
  • Establish multi-sector disease surveillance systems
icon group of people

In 2020 and 2021, CDC laboratory specialists partnered with Georgia’s NCDC to establish a specimen referral system and conduct trainings on identification and referral of Campylobacter


CDC helped establish the Pulse-field Gel Electrophoresis (PFGE) testing method for enteric pathogens in 2019

inspect graph

CDC continues to help facilitate PFGE for routine disease surveillance and detection of foodborne disease outbreaks

Icon test tube

Over 700 animal samples of the Akhmeta virus were collected and studied to establish the burden of disease and identify risk factors for human and livestock infections

Field Epidemiology Training Program (FETP)

CDC supported the NCDC to launch the advanced Field Epidemiology and Laboratory Training Program (FELTP) in Georgia, Armenia, and Azerbaijan in 2009 and Ukraine in 2015. FELTP-Advanced expanded on the traditional FETP to train scientists in epidemiology, veterinary epidemiology, and laboratory quality management systems. FETP and FELTP graduates from Georgia, Armenia, Azerbaijan, and Ukraine investigate disease outbreaks and help their countries adopt disease control measures. FELTP-Advanced graduates mentored FETP-Frontline participants before the course was transitioned over to the NCDC in 2020.

icon group of people

The Field Epidemiology and Laboratory Training Program (FELTP) Alumni Association was founded in 2019 and became a valuable asset for public health development and outbreak response

People world

Many FELTP graduates are now in public health leadership positions in their countries

Health worker

In 2021, CDC helped launch a regional FETP-Intermediate that includes 21 residents from Armenia, Azerbaijan, Georgia, Moldova, and Ukraine

Laboratory Systems Strengthening

CDC collaborates with Georgia’s NCDC to increase laboratory and workforce capacity in quality management systems, project management, and disease surveillance. In 2018, CDC helped establish the Lugar Center’s External Quality Assurance (EQA) program. CDC collaborates with the Lugar Center on proficiency testing and educational webinars on basic microbiology, laboratory testing, and bacteria isolation methods. CDC also supported Georgia to become the first country to implement a national Laboratory Information Management System (LIMS). The LIMS connects human and animal health with food safety and environmental health to rapidly identify and contain disease outbreaks across the country. Georgia’s laboratories and LIMS are critical assets to the country’s GHSA goals, One Health approach, and outbreak response.

Antimicrobial Resistance (AMR)

AMR and healthcare associated infections (HAIs) impact the quality of healthcare worldwide, increase morbidity and mortality, and lengthen hospital stays. In a recent national estimate, CDC found that compared to non-HAI cases, HAIs cost twice as much to treat. People with HAIs are also twice as likely to die. Since 2014, CDC also supports partners in Georgia to:

  • Achieve laboratory accreditation
  • Establish EQA and proficiency testing programs
  • Conduct IPC assessments of healthcare facilities
  • Monitor AMR patterns of enteric pathogens

CDC supported the development of antimicrobial resistance (AMR) infection prevention and control (IPC) guidelines that will be incorporated in the 2022 National IPC Program


CDC assisted the Lugar Center to provide proficiency test results to 23 laboratories in Georgia’s national AMR network


In partnership with the American Society of Microbiology, CDC delivered 10 webinar trainings, developed 7 protocols and standard operating procedures for the Lugar Center and 23 national AMR laboratories in 2021

Hepatitis C

In 2015, with CDC support, Georgia launched the world’s first national viral hepatitis elimination program. The program offers free testing and treatment to all citizens and is a global model for hepatitis elimination. Georgia’s hepatitis C virus (HCV) elimination program received CDC’s Honor Award for Excellence in Partnering in 2021. Georgia was also selected to pilot the World Health Organization’s Interim Guidance for Country Validation of Hepatitis Elimination.

Icon Magnify

As of 2021, over 2 million people have been screened for hepatitis C virus (HCV), 95,000 people with chronic HCV infections have been identified, and 76,000 people have been treated

icon shake

CDC worked with partners to support the Blood Safety Program by implementing nationwide nucleic acid testing on all blood donations

Icon target

Nationwide serosurveys show that the proportion of the population with chronic HCV infections decreased from 5.4% in 2015 to 1.8% in 2021

Icon world foot print

CDC helped develop the 2016-2021 and 2021-2025 Strategic Plan for the Elimination of Hepatitis in Georgia

Vaccine-Preventable Diseases

CDC, World Health Organization, and Georgian institutions have been immunization partners since the 1990s when CDC helped implement an immunization campaign to control a diphtheria outbreak. To achieve measles and rubella elimination in Georgia, CDC assists in analysis of epidemiologic data, surveillance reviews, immunization program reviews, and supplementary immunization activities. CDC continues to work to ensure Georgia remains polio-free.

CDC Staff in Georgia
  • 1 U.S. Assignee
  • 5 Locally Employed
Georgia at a Glance
  • Population: > 3 million
  • Per capita income: $14,160
  • Life expectancy: F 78 / M 70 years
  • Infant mortality rate: 8/1,000 live births

Sources: World Bank 2020, Georgia; Population Reference Bureau 2021, Georgia

Georgia Top 10 Causes of Death
  1. Ischemic heart disease
  2. Stroke
  3. Hypertensive heart disease
  4. Lung cancer
  5. Alzheimer’s disease
  6. Cirrhosis
  7. Diabetes
  8. Chronic obstructive pulmonary disease (COPD)
  9. Breast cancer
  10. Stomach cancer

Sources: GBD Compare 2019, Georgia

Page last reviewed: December 30, 2021
Content source: Global Health